Menu

Federal Contractor Misconduct Database (FCMD)

The federal government routinely awards contracts to companies with histories of misconduct, including contract fraud and other violations. POGO believes that providing this website will help to improve contracting decisions and increase public knowledge of how the government spends billions of taxpayer dollars each year. Read more…

Off-Label Promotion of Trileptal (Civil Litigation)

Novartis Pharmaceuticals Corporation (NPC) agreed to pay $237.5 million to resolve civil allegations under the False Claims Act that the company unlawfully marketed the epilepsy drug Trileptal and five other drugs (Diovan, Tekturna, Exforge, Sandostatin and Zelnorm) and paid illegal kickbacks to physicians to induce them to prescribe those drugs. Novartis also entered into a corporate integrity agreement with the Department of Health and Human Services.

Misconduct Type
Government Contract Fraud
Enforcement Agency
Health and Human Services
Contracting Party
Health and Human Services
Court Type
Civil
Disposition
Settlement
Date of Settlement Announcement
9/30/2010
Contractors Involved Penalty
Total
Novartis AG $237,500,000
Further Information Released
Corporate Integrity Agreement 7/11/2014
DOJ Press Release 11/30/2010
Law Firm Press Release 11/30/2010
Settlement Agreement 11/30/2010

See also:

Federal Contractor Misconduct Database